This fall’s updated COVID-19 vaccines should target the SARS-CoV-2 XFG variant, the US Food and Drug Administration’s (FDA’s) Vaccines and Related Biological Products Advisory Committee (VRBPAC) said ...
The FDA’s outside vaccine advisers plan to convene Thursday to recommend which Covid-19 strain vaccine manufacturers should target for the 2026-2027 season’s products, all while the country’s vaccine ...
The fast-growing Ebola outbreak in the Democratic Republic of Congo came to the world’s attention only a little more than a ...
The virus is spread through close contact with sick or deceased patients' bodily fluids, such as sweat, blood, feces or vomit. Healthcare workers and family members caring for sick patients face ...
SHELTON, CT / ACCESS Newswire / May 26, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, compares ...
The next pandemic may arrive in the United States via cruise ship or commercial flight originating halfway around the world.
Median overall survival, a secondary endpoint, reached nearly 3.5 years with Johnson & Johnson's RYBREVANT® plus LAZCLUZE® in atypical EGFR-mutated disease Consistent ...
Overlapping deadly outbreaks of hantavirus and Ebola have fuelled a resurgence of misinformation on social media, including ...
FDA panel backs fall Covid shot update to target the XFG variant, enabling manufacturers to reformulate vaccines for the upcoming surge season.
The targeted therapy sunvozertinib was more effective than standard platinum-based chemotherapy as a first-line treatment for ...
The sneaky virus poses serious health threats if it goes on to become a chronic disease. Clinical trial results suggest a new drug may cure 1 in 5 of those cases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results